Valuation Ipsen Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 11:30:30 10/07/2026 am IST			5-day change	1st Jan Change
167.80 ^EUR	+1.15%		-2.33%	+41.36%

09/07	Wall Street Ignores the Sirens
09/07	Ipsen Reports Positive Topline Phase III Results for Dysport in Both Episodic and Chronic Migraine	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	13,358	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	36.72%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	11,932	10,932	10,103
Change	-	16.81%	12.22%	1.81%	2.28%	29.33%	-8.38%	-7.58%
P/E	10.4x	12.9x	14x	26.7x	22.4x	14.7x	14.5x	14.5x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.66x	2.25x	1.94x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	9.84x	123.47x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	3.13x	2.98x	2.86x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.8x	2.44x	2.16x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	7.11x	6.45x	6.04x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	8.27x	7.43x	6.88x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	10.8x	9.54x	8.62x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	9.22%	10.5%	11.6%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.509	1.497	1.596
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.93%	0.92%	0.98%
EPS ²	7.76	7.81	7.73	4.15	5.32	11.04	11.21	11.22
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	13.7%	13.4%	14.2%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,266	4,481	4,667
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,678	1,696	1,674
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,442	1,472	1,468
Net income ¹	646.6	647.5	647.2	347.3	444.5	945.1	947.2	941.6
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,426	-2,426	-3,255
Reference price ²	80.50	100.50	107.90	110.70	119.00	162.70	162.70	162.70
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	82,100	-	-
Announcement Date	11/02/22	09/02/23	08/02/24	13/02/25	12/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.92x	12.63x	25.81x	0.57%	1,06000Cr
JOHNSON & JOHNSON	27.42x	6.3x	17.1x	2.08%	62TCr
ABBVIE INC.	30x	7.34x	15.02x	2.76%	44TCr
ROCHE HOLDING AG	17.98x	4.45x	11.01x	2.97%	33TCr
NOVARTIS AG	21.52x	5.52x	13.36x	2.86%	28TCr
ASTRAZENECA PLC	21.56x	4.53x	12.65x	1.94%	27TCr
NOVO NORDISK A/S	14.17x	5.3x	10.9x	3.52%	22TCr
AMGEN INC.	23.77x	6.31x	11.12x	2.78%	20TCr
GILEAD SCIENCES, INC.	-46.02x	5.6x	31.12x	2.5%	16TCr
Average	16.15x	6.44x	16.46x	2.44%	39.71TCr
Weighted average by Cap.	23.86x	7.85x	18.16x	2%